Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9249667 | 0.89 | ALDH1A1 (0.48) | ALDH1A1TSHRGAAHMGCRCHRM1 | |
| SCHEMBL8107357 | 0.89 | ALDH1A1 (0.48) | ALDH1A1TSHRHMGCRCHRM1TBXA2R | |
| SCHEMBL28189565 | 0.87 | ALDH1A1 (0.46) | ALDH1A1TSHRHMGCRCHRM1TBXA2R | |
| SCHEMBL14164382 | 0.87 | ALDH1A1 (0.46) | ALDH1A1TSHRHMGCRCHRM1TBXA2R | |
| SCHEMBL9728575 | 0.87 | ALDH1A1 (0.46) | ALDH1A1TSHRHMGCRCHRM1TBXA2R | |
| SCHEMBL17243716 | 0.85 | ALDH1A1 (0.41) | ALDH1A1TSHRHMGCRCHRM1TBXA2R | |
| Hydrochloric Acid SCHEMBL29290399 | 0.85 | ALDH1A1 (0.44) | ALDH1A1TSHRHMGCRCHRM1TBXA2R | |
| SCHEMBL324871 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHRHMGCRCHRM1TBXA2R | |
| SCHEMBL2829360 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHRHMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL667369 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHRHMGCRCHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190077116-A1 | FOAMED ACRYLIC-RESIN OBJECT, PROCESS FOR PRODUCING SAME, AND FIBER-REINFORCED COMPOSITE | SEKISUI PLASTICS CO., LTD. (JP) | 2019-03-14 | — | — | US | disclosed |
| EP-3348611-A1 | FOAMED ACRYLIC-RESIN OBJECT, PROCESS FOR PRODUCING SAME, AND FIBER-REINFORCED COMPOSITE | Sekisui Plastics Co., Ltd. (JP) | 2018-07-18 | — | — | EP | disclosed |
| EP-2231785-A2 | ISOMETRIC ISOINDOLINE YELLOW PIGMENT | BASF SE (DE) | 2010-09-29 | — | — | EP | disclosed |
| EP-2209467-A2 | MULTIPART CAPSULE FOR STAGED RELEASE OF ONE OR MORE SUBSTANCES | Glaxo Group Limited (GB) | 2010-07-28 | — | — | EP | disclosed |
| WO-2009074533-A2 | ISOMETRIC ISOINDOLINE YELLOW PIGMENT | BASF SE (CH) | 2009-06-18 | — | — | WO | disclosed |
| WO-2009050189-A2 | MULTIPART CAPSULE FOR STAGED RELEASE OF ONE OR MORE SUBSTANCES | GLAXO GROUP LIMITED (GB) | 2009-04-23 | — | — | WO | disclosed |
| US-20060141036-A1 | HMG-CoA reductase inhibitor extended release formulation | ANDRX LABS LLC (US) | 2006-06-29 | — | — | US | disclosed |
| US-6645524-B2 | Capsules housing compressed tablets or drug-containing beads, for administering isomers of solatol and other antiarrhythmics/adrenergic blocking agents | PIERCE MANAGEMENT LLC | 2003-11-11 | — | — | US | disclosed |
| US-6500457-B1 | PULSATILE RELEASE ORAL DOSAGE FORM FOR ADMINISTRATION OF SOTALOL OR AMIODARONE COMPRISING IMMEDIATE RELEASE DOSAGE UNIT COMPRISING FIRST DOSE, AND DELAYED RELEASE DOSAGE UNIT COMPRISING SECOND DOSE AND MEANS FOR DELAYING RELEASE | PEIRCE MANAGEMENT, LLC | 2002-12-31 | — | — | US | disclosed |
| CN-1202189-A | Vinylidene chloride polymer compositions and irradiated articles prepared therefrom | DOW CHEMICAL CO (US) | 1998-12-16 | — | — | CN | disclosed |